10,200 Shares in Merck & Co., Inc. $MRK Purchased by FNY Investment Advisers LLC

robot
Abstract generation in progress

FNY Investment Advisers LLC recently acquired 10,200 shares of Merck & Co., Inc. (NYSE:MRK) valued at approximately $1,073,000, establishing a new position in the company during the fourth quarter. This purchase contrasts with recent insider selling activity, though institutional ownership accounts for 76.07% of the stock. Analysts currently rate Merck as a “Moderate Buy” with an average price target of $127.13, following positive developments such as EU approval for a KEYTRUDA combination and strong Phase 3 data for an oral PCSK9 candidate.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin